Biotest AG — Director's Dealing 2018

Sep 5, 2018

News Details

Directors’ Dealings | 5 September 2018 11:00

DGAP-DD: Biotest AG english

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

05.09.2018 / 10:59

The issuer is solely responsible for the content of this announcement.

---

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:	Dr.
First name:	Martin
Last name(s):	Reinecke

2. Reason for the notification

a) Position / status

Position:	Senior Vice President plasma alliances and proteine supply

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Biotest AG

b) LEI

529900JVX7RPXBLYUD89

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	DE0005227235

b) Nature of the transaction

Disposal
Transaction linked to the exercise of share option programmes

c) Price(s) and volume(s)

Price(s)	Volume(s)
24.35 EUR	2435.00 EUR

d) Aggregated information

Price	Aggregated volume
24.35 EUR	2435.00 EUR

e) Date of the transaction

2018-08-31; UTC+2

f) Place of the transaction

Name:	XETRA
MIC:	XETR

---

05.09.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de

---

Language:	English
Company:	Biotest AG
	Landsteinerstraße 5
	63303 Dreieich
	Germany
Internet:	http://www.biotest.de

End of News	DGAP News Service